Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PBF-1129 |
| Trade Name | |
| Synonyms | PBF1129|PBF 1129 |
| Drug Descriptions |
PBF-1129 inhibits the adenosine A2B receptor (ADORA2B), which may lead to tumor microenviroment modulation and inhibition of tumor growth and metastasis (Journal of Thoracic Oncology, Jan 2017 12(Suppl 1):S1013). |
| DrugClasses | Adenosine Targeting 24 |
| CAS Registry Number | NA |
| NCIT ID | C148435 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Nivolumab + PBF-1129 | Nivolumab PBF-1129 | 0 | 1 |
| PBF-1129 | PBF-1129 | 0 | 1 |